| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |